Showing results (161-170 of 218) with videos related to
Sort By:
Pageof 22
Contemporary Clinical Trials|July 30, 2024
Design and methods of the StepByStep randomized trial of a mobile health and social media physical activity intervention among adolescent and young adult survivors of childhood cancer: A report from the Children's Oncology GroupLeah J Beight, Jason A Mendoza, Wendy M Leisenring, et al.Bone Marrow Transplantation|September 27, 2020
Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approachMasumi Ueda Oshima, Brenda M Sandmaier, Effie Petersdorf, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2017
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell TransplantationAndrew C Dietz, Parinda A Mehta, Adrianna Vlachos, et al.Journal of Immigrant and Minority Health|October 14, 2025
Perspective of Hispanic Cancer Survivors on Survivorship Care Plans: A Qualitative StudyJean C Yi, Ethan Lee, Catherine Duggan, et al.Journal of Cancer Survivorship : Research and Practice|February 15, 2025
Enhancing survivorship care among Hispanic/Latino cancer survivors via lay health educators: results of a pilot randomized trialEric J Chow, Nancy A Blythe, Kara L Cushing-Haugen, et al.Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCTAndrew C Dietz, Sharon A Savage, Adrianna Vlachos, et al.Blood|June 10, 2011
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)Saro H Armenian, Can-Lan Sun, Toana Kawashima, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2012
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolismMary Eapen, Kwang Woo Ahn, Paul J Orchard, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 3, 2020
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant CyclophosphamideKanwaldeep K Mallhi, Meera A Srikanthan, Kelsey K Baker, et al.Pageof 22